Please login to the form below

Not currently logged in
Email:
Password:

MSD/Serum vaccine partnership

MSD is to form a partnership with India-based Serum Institute to develop and market a pneumococcal conjugate vaccine (PCV) for use in developing countries

SD (known as Merck in the US and Canada) is to form a partnership with India-based Serum Institute to develop and market a pneumococcal conjugate vaccine (PCV) for use in developing countries.

As part of the collaboration, the companies will form a product advisory committee to oversee all activities required to develop and seek approval for the PCV and pursue World Health Organisation (WHO) prequalification.

MSD, through an affiliate, will receive rights to market the PCV in designated territories and Serum will receive rights in other territories. Serum is the world's largest manufacturer of diphtheria, pertussis and tetanus (DTP) and MMR vaccines.

Both companies will contribute to the development and manufacture of PCV. Financial details of this agreement are not disclosed.

Pneumococcal disease is a bacterial infection that causes pneumonia, meningitis, sepsis and other life-threatening ailments.

It is estimated at least one million children die of pneumococcal disease every year, with developing countries hit the hardest.

3rd August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics